General MedicationsTOPICALGeneric
FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE
Standard Dose
0.005%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview FLUTICASONE PROPIONATE is listed in Drugs@FDA under application 215343 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient FLUTICASONE PROPIONATE Form and strength OINTMENT;TOPICAL - 0.005% Sponsor BRIGHT Submission history Latest submission status date: 2023-09-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUTICASONE PROPIONATE is listed in Drugs@FDA under application 215343 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FLUTICASONE PROPIONATE Form and strength OINTMENT;TOPICAL - 0.005% Sponsor BRIGHT Submission history Latest submission status date: 2023-09-01 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.